AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Corporate overview and IRD Invest 2021 presentation
1AD released this announcement to the ASX on 21 September 2021, 8:47. The announcement is marked as price sensitive, and is 62 page(s) in length and 12.18MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Corporate overview and IRD Invest 2021 presentation | 21 September 2021, 8:47 |
| $4.0M Non-Dilutive Financing with Victorian Government | 20 September 2021, 8:40 |
| Appendix 4G and Corporate Governance Statement | 27 August 2021, 10:22 |
| Annual Report to shareholders | 27 August 2021, 10:21 |
If you were already registered, log in here.
If you were already registered, log in here.